Tolmar, Inc. recalls Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted befo
Recalled October 4, 2023 · FDA recall D-1178-2023 · Tolmar
Hazard
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product. · FDA Class III
Units
2990 cartons
Sold at
Nationwide in the US.
Description
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Product
Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.
Manufacturer(s)
Tolmar, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →